BPC-157 (Pentadecapeptide)

The Gastric Juice Origin

UKPWritten & reviewed by William Heath · Editor, UK Peptides research library2 min readLast reviewed 2026-08-233 cited sources

The short answer

BPC-157 corresponds to a fifteen-residue partial sequence of body protection compound, a protein reported in human gastric juice. The synthetic peptide is not isolated from the stomach. It is made by solid-phase synthesis from a sequence found there.

Key facts

Source protein
Body protection compound
Found in
Human gastric juice
BPC-157
A 15-residue partial sequence
Production
Solid-phase synthesis
Not
Extracted from gastric juice
Reported property
Stability in gastric juice

What was found where

The Zagreb group reported a protein in human gastric juice which they named body protection compound. BPC-157 is a fifteen-residue stretch of that protein's sequence, synthesised independently. The distinction matters: the peptide sold and studied is a synthetic construct, not a purified natural product.

Why gastric juice is an interesting place to look

It is one of the most chemically aggressive environments in the body: strongly acidic and rich in pepsin. Anything surviving there has properties worth understanding, and the stomach lining's ability to withstand its own secretions is a real physiological question. Looking for protective factors in that fluid is a reasonable research strategy.

Research material referenced

BPC-157 5mg, third-party HPLC tested

Buy BPC-157 · £16.95

The stability claim this origin supports

The compound is routinely described as stable in human gastric juice, which is the specific property its name and its literature emphasise. Most peptides are destroyed there within minutes. If BPC-157 resists that, its proline content is a plausible structural explanation, since proline-adjacent bonds are poor substrates for most proteases including pepsin.

What a fragment relationship does not establish

That the fifteen-residue peptide does what the parent protein does. This is the same caution that applies to TB-500 and thymosin beta-4: a fragment is a different molecule, and activity of the parent does not transfer automatically. Here the parent protein is much less characterised than thymosin beta-4, so the comparison is harder to make in either direction.

Reading the origin claim carefully

Endogenous origin is frequently deployed as an argument for safety or naturalness. It establishes neither. A sequence occurring in a protein somewhere in the body says nothing about what happens when a fragment of it is synthesised and administered at a chosen concentration by a chosen route.

Frequently asked questions

Is BPC-157 extracted from gastric juice?

No. It is synthesised. The sequence corresponds to part of a protein reported in gastric juice.

Is BPC-157 naturally occurring?

The sequence occurs within a larger protein. The fifteen-residue peptide as such is a synthetic construct.

Does the origin make it safe?

No. Endogenous origin of a sequence says nothing about what a synthetic fragment does when administered.

Continue researching

Peer-reviewed guides, comparators and matched reference materials.

Primary sources & clinical trials

Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.

Browse the wider literature

Live database searches, not fixed citations. Results change as new work is indexed.

UKP

Written and reviewed by

William Heath · Editor, UK Peptides research library

William Heath edits the UK Peptides research library. He is responsible for what is published here: every article is sourced to primary literature, every purity or identity statement traces to a signed third-party certificate for a specific lot, and corrections are made in place with the review date updated. No scientific or medical credentials are claimed on this site; the evidence is carried by the cited sources and the certificates, not by the byline.

More BPC-157 (Pentadecapeptide) articles

Research use only. The information above is provided for scientific and educational reference. Compounds referenced are not approved for human use and are supplied for in vitro research or reference-material purposes only. No efficacy, safety, or therapeutic claims are made.